Bioventus (BVS) Common Equity (2020 - 2026)
Bioventus' (BVS) quarterly Common Equity came in at $234.3 million in Q1 2026, up 26.3% YoY from $185.5 million in Q1 2025, and up 27.25% on a QoQ basis from $184.1 million in Q4 2025.
Bioventus (BVS) Common Equity (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Common Equity data on file, last reported at $234.3 million in Q1 2026.
- Quarterly Common Equity rose 26.3% year-over-year to $234.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234.3 million (up 26.3% YoY) and the FY2025 annual result came in at $184.1 million, down 0.81% from the prior year.
- Common Equity rose to $234.3 million in Q1 2026, from $184.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $593.8 million in Q2 2022 to a low of $166.1 million in Q3 2025.
- A 5-year average of $277.7 million and a median of $221.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity soared 169.91% — and 2023, when it slumped 60.59%.
- Tracing BVS's Common Equity over 5 years: stood at $412.2 million in 2022, then tumbled by 46.36% to $221.1 million in 2023, then dropped by 16.06% to $185.6 million in 2024, then decreased by 0.81% to $184.1 million in 2025, then advanced by 27.25% to $234.3 million in 2026.
- The last three Common Equity figures came in at $234.3 million (Q1 2026), $184.1 million (Q4 2025), and $166.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 277.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 277.41 Mn |
| Mar 28, 2026 | 234.27 Mn |
| Dec 31, 2025 | 184.11 Mn |
| Sep 27, 2025 | 166.10 Mn |
| Jun 28, 2025 | 201.30 Mn |
| Mar 29, 2025 | 185.48 Mn |
| Dec 31, 2024 | 185.60 Mn |
| Sep 28, 2024 | 186.83 Mn |
| Jun 29, 2024 | 189.06 Mn |
| Mar 30, 2024 | 217.43 Mn |
| Dec 31, 2023 | 221.12 Mn |
| Sep 30, 2023 | 226.46 Mn |
| Jul 1, 2023 | 233.34 Mn |
| Apr 1, 2023 | 240.36 Mn |
| Dec 31, 2022 | 412.22 Mn |
| Oct 1, 2022 | 451.04 Mn |
| Jul 2, 2022 | 592.08 Mn |
| Apr 2, 2022 | 593.81 Mn |
| Dec 31, 2021 | 607.66 Mn |
| Oct 2, 2021 | 230.50 Mn |